Trial Outcomes & Findings for Comparison of Coagulation Factors During Laparoscopic Cholecystectomy (NCT NCT02568852)
NCT ID: NCT02568852
Last Updated: 2016-06-30
Results Overview
group1 and group 2(Duration of Operation)
COMPLETED
NA
50 participants
up to 2 hours
2016-06-30
Participant Flow
Participant milestones
| Measure |
Group 1
Laparoscopic cholecystectomy under general anaesthesia
|
Group 2
Laparoscopic cholecystectomy under combined anaesthesia (Spino epidural).
|
|---|---|---|
|
Overall Study
STARTED
|
25
|
25
|
|
Overall Study
COMPLETED
|
25
|
25
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Comparison of Coagulation Factors During Laparoscopic Cholecystectomy
Baseline characteristics by cohort
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in under 10 mmHg pneumoperitoneum
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in under 14 mmHg pneumoperitoneum
|
Total
n=50 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
46 years
n=5 Participants
|
52 years
n=7 Participants
|
48 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=5 Participants
|
19 Participants
n=7 Participants
|
39 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Region of Enrollment
Turkey
|
25 participants
n=5 Participants
|
25 participants
n=7 Participants
|
50 participants
n=5 Participants
|
|
ASA(American Society of Anesthesiologists ) scores
|
1 Scores on a scale(min:1 and max:6)
n=5 Participants
|
2 Scores on a scale(min:1 and max:6)
n=7 Participants
|
2 Scores on a scale(min:1 and max:6)
n=5 Participants
|
|
BMI
|
28.1 kg/m^2
STANDARD_DEVIATION 4.0 • n=5 Participants
|
28.2 kg/m^2
STANDARD_DEVIATION 3.5 • n=7 Participants
|
28.15 kg/m^2
STANDARD_DEVIATION 3.72 • n=5 Participants
|
PRIMARY outcome
Timeframe: up to 2 hoursPopulation: All patients have gall bladder disease who are between 18-80 years old.
group1 and group 2(Duration of Operation)
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
Duration of Operation
|
54 minutes
Interval 45.0 to 80.0
|
65 minutes
Interval 53.0 to 92.0
|
SECONDARY outcome
Timeframe: pre-operativePopulation: All patients have gall bladder disease who are between 18-80 years old.
A soluble plasma glycoprotein, that is converted by thrombin into fibrin during blood clot formation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
Fibrinogen Level
|
219 mg/dL
Interval 138.0 to 318.0
|
261 mg/dL
Interval 87.0 to 395.0
|
SECONDARY outcome
Timeframe: Post-operative 1 st hourPopulation: All patients have gall bladder disease who are between 18-80 years old.
A soluble plasma glycoprotein, that is converted by thrombin into fibrin during blood clot formation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
Fibrinogen Level
|
253 mg/dL
Interval 214.0 to 382.0
|
320 mg/dL
Interval 171.0 to 495.0
|
SECONDARY outcome
Timeframe: Post-operative 24th hourPopulation: All patients have gall bladder disease who are between 18-80 years old.
A soluble plasma glycoprotein, that is converted by thrombin into fibrin during blood clot formation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
Fibrinogen Level
|
352 mg/dL
Interval 258.0 to 496.0
|
421 mg/dL
Interval 250.0 to 760.0
|
SECONDARY outcome
Timeframe: pre-operativePopulation: All patients have gall bladder disease who are between 18-80 years old.
measures of the extrinsic pathway of coagulation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
PT(Prothrombin Time)
|
11.94 seconds
Standard Deviation 0.64
|
11.78 seconds
Standard Deviation 0.75
|
SECONDARY outcome
Timeframe: Post-operative 1st hourmeasures of the extrinsic pathway of coagulation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
PT(Prothrombin Time)
|
12.1 seconds
Standard Deviation 0.53
|
12.69 seconds
Standard Deviation 0.84
|
SECONDARY outcome
Timeframe: Post-operative 24th hoursPopulation: All patients have gall bladder disease who are between 18-80 years old.
measures of the extrinsic pathway of coagulation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
PT(Prothrombin Time)
|
12.43 seconds
Standard Deviation 0.86
|
13.63 seconds
Standard Deviation 1.07
|
SECONDARY outcome
Timeframe: pre-operativePopulation: All patients have gall bladder disease who are between 18-80 years old.
A fibrin degradation product (or FDP) present in the blood after a blood clot is degraded by fibrinolysis
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
D-Dimer
|
0.31 mg/L
Standard Deviation 0.08
|
0.34 mg/L
Standard Deviation 0.10
|
SECONDARY outcome
Timeframe: Post-operative 1st hourPopulation: All patients have gall bladder disease who are between 18-80 years old.
A fibrin degradation product (or FDP) present in the blood after a blood clot is degraded by fibrinolysis
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
D-Dimer
|
0.56 mg/L
Standard Deviation 0.22
|
1.06 mg/L
Standard Deviation 0.7
|
SECONDARY outcome
Timeframe: Post-operative 24th hoursPopulation: All patients have gall bladder disease who are between 18-80 years old.
A fibrin degradation product (or FDP) present in the blood after a blood clot is degraded by fibrinolysis
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
D-Dimer
|
0.91 mg/L
Standard Deviation 0.34
|
1.61 mg/L
Standard Deviation 0.95
|
SECONDARY outcome
Timeframe: pre-operativePopulation: All patients have gall bladder disease who are between 18-80 years old.
measures of the intrinsic pathway of coagulation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
aPTT(Activated Partial Thromboplastin Time)
|
22.80 seconds
Standard Deviation 1.48
|
25.0 seconds
Standard Deviation 2.86
|
SECONDARY outcome
Timeframe: Post-operative 1st hourPopulation: All patients have gall bladder disease who are between 18-80 years old.
measures of the intrinsic pathway of coagulation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
aPTT(Activated Partial Thromboplastin Time)
|
23.42 seconds
Standard Deviation 1.54
|
25.25 seconds
Standard Deviation 2.35
|
SECONDARY outcome
Timeframe: Post-operative 24th hoursPopulation: All patients have gall bladder disease who are between 18-80 years old.
measures of the intrinsic pathway of coagulation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
aPTT(Activated Partial Thromboplastin Time)
|
24.54 seconds
Standard Deviation 2.16
|
26.92 seconds
Standard Deviation 2.92
|
SECONDARY outcome
Timeframe: pre-operativePopulation: All patients have gall bladder disease who are between 18-80 years old.
measures of the extrinsic and intrinsic pathway of coagulation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
Thrombin Time(TT)
|
19.88 seconds
Standard Deviation 1.58
|
20.57 seconds
Standard Deviation 2.12
|
SECONDARY outcome
Timeframe: Post-operative 1st hourPopulation: All patients have gall bladder disease who are between 18-80 years old.
measures of the extrinsic and intrinsic pathway of coagulation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
Thrombin Time(TT)
|
17.78 seconds
Standard Deviation 0.74
|
17.61 seconds
Standard Deviation 1.02
|
SECONDARY outcome
Timeframe: Post-operative 24th hoursPopulation: All patients have gall bladder disease who are between 18-80 years old.
measures of the extrinsic and intrinsic pathway of coagulation
Outcome measures
| Measure |
Group 1
n=25 Participants
Laparoscopic cholecystectomy in general anaesthesia
Combined anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under combined spinal epidural anaesthesia
|
Group 2
n=25 Participants
Laparoscopic cholecystectomy in combined anaesthesia (Spino epidural).
General anaesthesia: 10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia
|
|---|---|---|
|
Thrombin Time(TT)
|
16.06 seconds
Standard Deviation 1.05
|
16.01 seconds
Standard Deviation 0.72
|
Adverse Events
Group 1
Group 2
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Group 1
n=25 participants at risk
Laparoscopic cholecystectomy in under general anaesthesia.(10 mmHg CO2 pneumoperitoneum)
|
Group 2
n=25 participants at risk
Laparoscopic cholecystectomy in under spinal epidural anaesthesia.(10 mmHg CO2 pneumoperitoneum)
|
|---|---|---|
|
Cardiac disorders
Hypotension
|
4.0%
1/25 • Number of events 1 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
|
8.0%
2/25 • Number of events 2 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
|
|
Renal and urinary disorders
urinary retension
|
0.00%
0/25 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
|
4.0%
1/25 • Number of events 1 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
|
|
Gastrointestinal disorders
Nausea/vomiting
|
16.0%
4/25 • Number of events 4 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
|
4.0%
1/25 • Number of events 1 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
|
|
Nervous system disorders
headache
|
0.00%
0/25 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
|
4.0%
1/25 • Number of events 1 • up to 24 weeks
In this time period, hypotension,urinary retention,nausea and headache were observed.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place